On the other hand, four tumors (ACC, LGG, SRAC, and TGCT) demonstrated nonsignificant differences and only one tumor, LAML, experienced a significantly higher ECT2 expression in normal tissues versus cancerous ones (Supplementary Figure S1). This evidence concerns the gene ECT2 and adrenal cortex carcinoma.